Czech National Bank Has $24.28 Million Holdings in CME Group Inc. $CME

Key Points

• The Czech National Bank increased its holdings in CME Group Inc. by 6.4% in Q2, now owning 88,083 shares worth approximately $24.28 million.
• Insiders traded shares recently, with a notable sale by Sunil Cutinho of 11,896 shares for over $3.2 million, which reduced their ownership by 40.55%.
• CME Group announced a quarterly dividend of $1.25, resulting in an annualized dividend of $5.00 and a yield of 1.9%, to be paid on September 25th.

Czech National Bank grew its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 6.4% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 88,083 shares of the financial services provider's stock after buying an additional 5,315 shares during the quarter. Czech National Bank's holdings in CME Group were worth $24,277,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Wayfinding Financial LLC acquired a new position in shares of CME Group in the first quarter valued at approximately $25,000. Webster Bank N. A. boosted its holdings in shares of CME Group by 206.9% in the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider's stock valued at $25,000 after buying an additional 60 shares during the period. Cornerstone Planning Group LLC boosted its holdings in shares of CME Group by 122.2% in the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock valued at $26,000 after buying an additional 55 shares during the period. Golden State Wealth Management LLC lifted its position in shares of CME Group by 612.5% in the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after purchasing an additional 98 shares in the last quarter. Finally, Ransom Advisory Ltd bought a new stake in shares of CME Group in the first quarter worth $31,000. Institutional investors and hedge funds own 87.75% of the company's stock.

Insider Buying and Selling at CME Group

In other CME Group news, insider Sunil Cutinho sold 11,896 shares of the company's stock in a transaction on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total value of $3,229,407.12. Following the transaction, the insider directly owned 17,440 shares in the company, valued at $4,734,436.80. The trade was a 40.55% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director William R. Shepard acquired 256 shares of the firm's stock in a transaction on Wednesday, June 25th. The stock was bought at an average price of $270.53 per share, for a total transaction of $69,255.68. Following the completion of the acquisition, the director owned 258,196 shares of the company's stock, valued at approximately $69,849,763.88. The trade was a 0.10% increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.30% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

CME has been the topic of a number of research reports. Wall Street Zen lowered shares of CME Group from a "hold" rating to a "sell" rating in a research report on Sunday, July 13th. UBS Group cut their price objective on shares of CME Group from $305.00 to $285.00 and set a "neutral" rating on the stock in a research report on Monday, September 8th. Piper Sandler boosted their price objective on shares of CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 15th. Citigroup boosted their price objective on shares of CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a research report on Thursday, July 3rd. Finally, Barclays set a $298.00 price objective on shares of CME Group and gave the stock an "equal weight" rating in a research report on Thursday, July 24th. Four equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $260.60.

CME Group Stock Performance

NASDAQ CME opened at $258.83 on Tuesday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The firm's fifty day moving average price is $273.13 and its two-hundred day moving average price is $270.62. CME Group Inc. has a 1 year low of $212.38 and a 1 year high of $290.79. The firm has a market capitalization of $93.28 billion, a P/E ratio of 25.06, a price-to-earnings-growth ratio of 4.75 and a beta of 0.43.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The firm had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period in the prior year, the firm posted $2.56 earnings per share. The company's quarterly revenue was up 10.4% compared to the same quarter last year. As a group, research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be issued a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date is Tuesday, September 9th. CME Group's payout ratio is currently 48.40%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.